Get started
Author

Maria S. Iliou

Observed names: M S Iliou, M. Iliou, M. S. Iliou, Maria Iliou
ORCID: 0000-0001-7268-2731
Observed ORCID: 0000-0001-7268-2731
OpenAlex ID: A5013490462
Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs
2019 · Susannah L. Hewitt, Ailin Bai, et al. · Science Translational Medicine · 337
Epigenetic alterations involved in cancer stem cell reprogramming
2012 · Purificación Muñoz, Maria S. Iliou, et al. · Molecular Oncology · 207
PDF
Impaired DICER1 function promotes stemness and metastasis in colon cancer
2013 · M S Iliou, V da Silva-Diz, et al. · Oncogene · 100
PDF
In vitro models of cancer stem cells and clinical applications
2016 · Sara S. Franco, Karolina Szczesna, et al. · BMC Cancer · 92
PDF
Quaternary structure of the human Cdt1-Geminin complex regulates DNA replication licensing
2009 · V. De Marco, P. J. Gillespie, et al. · Proceedings of the National Academy of Sciences · 84
PDF
Abstract 1262: BLU-701 is a highly potent, brain-penetrant and WT-sparing next-generation EGFR TKI for the treatment of sensitizing (ex19del, L858R) and C797S resistance mutations in metastatic NSCLC
2021 · Chiara Conti, John Campbell, et al. · Cancer Research · 29
Geminin Cleavage during Apoptosis by Caspase-3 Alters Its Binding Ability to the SWI/SNF Subunit Brahma
2007 · Vassilis Roukos, Maria S. Iliou, et al. · Journal of Biological Chemistry · 28
PDF
Bivalent histone modifications in stem cells poise miRNA loci for CpG island hypermethylation in human cancer
2011 · Maria S. Iliou, Amaia Lujambio, et al. · Epigenetics · 16
Reduced Geminin levels promote cellular senescence
2012 · Maria S. Iliou, Panorea Kotantaki, et al. · Mechanisms of Ageing and Development · 15
Abstract 3328: Antitumor activity of BLU-945 and BLU-701 as single agents and in combination in EGFR L858R-driven models of NSCLC
2022 · Luz Tavera, Stefanie Schalm, et al. · Cancer Research · 13
BLU-945 or BLU-701 as single agents versus their combination with osimertinib in EGFR L858R driven tumor models
2022 · L. Tavera, J. Campbell, et al. · European Journal of Cancer · 5
BLU-701 tumour suppression and intracranial activity as a single agent and in combination with BLU-945 in models of non-small cell lung cancer (NSCLC) driven by EGFR mutations
2022 · Luz Tavera, Zhuo Zhang, et al. · Lung Cancer · 4
Abstract 5795: The discovery of BLU-020: A potent and selective degrader of CDK2 for the treatment of CCNE1 aberrant cancers
2026 · Phil Ramsden, Dean Zhang, et al. · Cancer Research
Works count: 13
Citation count: 930
H-index: 10
I10-index: 10
Year
Topic
Type